Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Santium Pharma AB
AB
In liquidation
Org 5591120828
Other research and experimental development on natural sciences and engineering
·
NACE 7219
Est. 2017 · 9 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
Santium Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AM
Anne Marita Elisabet Rosenberg
Liquidator
Liquidator
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
LA
Leif Axel Eriksson
Board of Directors
Board of Directors
2019 – 2021
LS
Linus Sten Erik Bille
Board of Directors
Board of Directors
2019 – 2020
LP
Lars Per Olov Palmqvist Morin
Board of Directors
Board of Directors
2019 – 2020
JR
Jan-Erik Rosenberg
Board of Directors
Board of Directors
2019 – 2020
BS
Björn Sverre Strandwitz
Chairman
Chairman
2019 – 2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Santium Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
